Optimization of in vitro vascular cell transfection with non-viral vectors for in vivo applications

Journal of Gene Medicine

Volumn 6, Issue 10, 2004, Pages 1112-1124

  Elmadbouh, Ibrahim ^a   Rossignol, Patrick ^a   Meilhac, Olivier ^a   Vranckx, Roger ^a   Pichon, Chantal ^b   Pouzet, Bruno ^a   Midoux, Patrick ^b   Michel, Jean Baptiste ^a  

^a BICHAT HOSPITAL   (France)

^b CNRS   (France)

Author keywords

Cationic vectors; Cell therapy; Gene therapy; Myocardial infarction; Secreted alkaline phosphatase; Zinc chloride

Indexed keywords

ALKALINE PHOSPHATASE; CATION; COMPLEMENTARY DNA; LIPOSOME; PLASMID DNA; POLYETHYLENEIMINE; POLYLYSINE; REAGENT; ZINC CHLORIDE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVITY; ENZYME RELEASE; FIBROBLAST CULTURE; GENE EXPRESSION; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; RABBIT; RAT; RAT STRAIN; REPORTER GENE; SMOOTH MUSCLE FIBER; SOMATIC CELL; STATISTICAL ANALYSIS; TRANSGENE; VASCULAR SMOOTH MUSCLE;

ALKALINE PHOSPHATASE; ANIMALS; AORTA; CATIONS; CELL SURVIVAL; CELLS, CULTURED; CHLORIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; HUMANS; MYOCYTES, SMOOTH MUSCLE; PLASMIDS; POLYETHYLENEIMINE; POLYLYSINE; RABBITS; RATS; RATS, INBRED LEW; TIME FACTORS; TRANSFECTION; ZINC; ZINC COMPOUNDS;

ORYCTOLAGUS CUNICULUS;

EID: 13644263480     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.604     Document Type: Article

References (48)

1. Yang NS. Gene transfer into mammalian somatic cells in vivo. Crit Rev Biotechnol 1992; 12: 335-356.
2. Valdenaire O, Lepailleur-Enouf D, Egidy G, et al. A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization. Eur J Biochem 1999; 264: 341-349.
3. Veit K, Boissel JP, Buerke M, Grosser T, Meyer J, Darius H. Highly efficient liposome-mediated gene transfer of inducible nitric oxide synthase in vivo and in vitro in vascular smooth muscle cells. Cardiovasc Res 1999; 43: 808-822.
4. Hellgren I, Drvota V, Pieper R, et al. Highly efficient cell-mediated gene transfer using non-viral vectors and FuGene6: in vitro and in vivo studies. Cell Mol Life Sci 2000; 57: 1326-1333.
5. Neuhuber B, Huang DI, Daniels MP, Torgan CE. High efficiency transfection of primary skeletal muscle cells with lipid-based reagents. Muscle Nerve 2002; 26: 136-140.
6. Pichon C, Guerin B, Refregiers M, Goncalves C, Vigny P, Midoux P. Zinc improves gene transfer mediated by DNA/cationic polymer complexes. J Gene Med 2002; 4: 548-559.
7. Allaire E, Forough R, Clowes M, Starcher B, Clowes AW. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest 1998; 102: 1413-1420.
8. Gomes D, Louedec L, Plissonnier D, et al. Endoluminal smooth muscle cell seeding limits intimal hyperplasia. J Vasc Surg 2001; 34: 707-715.
9. Pelisek J, Engelmann MG, Golda A, et al. Optimization of nonviral transfection: variables influencing liposome-mediated gene transfer in proliferating vs. quiescent cells in culture and in vivo using a porcine restenosis model. J Mol Med 2002; 80: 724-736.
10. Li RK, Jia ZQ, Weisel RD, Merante F, Mickle DA. Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol 1999; 31: 513-522.
11. Feld Y, Melamed-Frank M, Kehat I, Tal D, Marom S, Gepstein L. Electrophysiological modulation of cardiomyocytic tissue by transfected fibroblasts expressing potassium channels: a novel strategy to manipulate excitability. Circulation 2002; 105: 522-529.
12. Campbell AI, Zhao Y, Sandhu R, Stewart DJ. Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension. Circulation 2001; 104: 2242-2248.
13. Yang TT, Sinai P, Kitts PA, Kain SR. Quantification of gene expression with a secreted alkaline phosphatase reporter system. Biotechniques 1997; 23: 1110-1104.
14. Michel JB, Lattion AL, Salzmann JL, et al. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res 1988; 62: 641-650.
15. Pouzet B, Ghostine S, Vilquin JT, et al. Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors? Circulation 2001; 104 1223-1228.
16. Gaertner R, Prunier F, Philippe M, Louedec L, Mercadier JJ, Michel JB. Scar and pulmonary expression and shedding of ACE in rat myocardial infarction. Am J Physiol Heart Circ Physiol 2002; 283 H156-164.
17. Battle T, Arnal JF, Challah M, Michel JB. Selective isolation of rat aortic wall layers and their cell types in culture - application to converting enzyme activity measurement. Tissue Cell 1994; 26 943-955.
18. Escargueil-Blanc I, Meilhac O, Pieraggi MT, Arnal JF, Salvayre R, Negre-Salvayre A. Oxidized LDLs induce massive apoptosis of cultured human endothelial cells through a calcium-dependent pathway. Prevention by aurintricarboxylic acid. Arterioscler Thromb Vasc Biol 1997; 17: 331-339.
19. Turunen MP, Hiltunen MO, Ruponen M, et al. Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes. Gene Ther 1999; 6: 6-11.
20. Midoux P, Monsigny M. Efficient gene transfer by histidylated polylysine/pDNA complexes. Bioconjug Chem 1999; 10: 406-411.
21. Gebhart CL, Kabanov AV. Evaluation of polyplexes as gene transfer agents. J Control Release 2001; 73: 401-416.
22. Armeanu S, Pelisek J, Krausz E. et al. Optimization of nonviral gene transfer of vascular smooth muscle cells in vitro and in vivo. Mol Ther 2000; 1: 366-375.
23. Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362: 697-703.
24. Yamaguchi J. Kusano KF, Masuo O. et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003; 107: 1322-1328.
25. Yla-Herttuala S, Martin JF. Cardiovascular gene therapy. Lancet 2000; 355: 213-222.
26. Maeda Y, Ikeda U, Ogasawara Y, et al. Gene transfer into vascular cells using adeno-associated virus (AAV) vectors. Cardiovasc Res 1997; 35: 514-521.
27. Scott-Burden T, Tock CL, Schwarz JJ, Casscells SW, Engler DA. Genetically engineered smooth muscle cells as linings to improve the biocompatibility of cardiovascular prostheses. Circulation 1996; 94: II235-II238.
28. Lawrie A, Brisken AF, Francis SE, Cumberland DC, Crossman DC, Newman CM. Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther 2000; 7: 2023-2027.
29. Faneca H, Simoes S, de Lima MC. Evaluation of lipid-based reagents to mediate intracellular gene delivery. Biochim Biophys Acta 2002; 1567: 23-33.
30. Keogh MC, Chen D, Lupu F, et al. High efficiency reporter gene transfection of vascular tissue in vitro and in vivo using a cationic lipid-DNA complex. Gene Ther 1997; 4: 162-171.
31. Li JM, Collins L, Zhang X, Gustafsson K, Fabre JW. Efficient gene delivery to vascular smooth muscle cells using a nontoxic, synthetic peptide vector system targeted to membrane integrins: a first step toward the gene therapy of chronic rejection. Transplantation 2000; 70 1616-1624.
32. Pickering JG, Jekanowski J, Weir L, Takeshita S, Losordo DW, Isner JM. Liposome-mediated gene transfer into human vascular smooth muscle cells. Circulation 1994; 89: 13-21.
33. 2+ with phospholipid membranes. Biophys Chem 2001; 90: 57-74.
34. Lechardeur D, Sohn KJ, Haardt M, et al. Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther 1999; 6: 482-497.
35. Niedzinski EJ, Olson DC, Chen YJ, et al. Zinc enhancement of nonviral salivary gland transfection. Mol Ther 2003; 7: 396-400.
36. Dreosti IE. Zinc and the gene. Mutat Res 2001; 475 161-167.
37. Fuchs O, Babusiak M, Vyoral D, Petrak J. Role of zinc in eukaryotic cells, zinc transporters and zinc-containing proteins. Review article. Sb Lek 2003; 104: 157-170.
38. Sondergaard LG, Stoltenberg M, Flyvbjerg A, et al. Zinc ions in beta-cells of obese, insulin-resistant, and type 2 diabetic rats traced by autometallography. Apmis 2003; 111: 1147-1154.
39. Ripa S, Ripa R. Zinc cellular traffic: physiopathological considerations. Minerva Med 1995; 86: 37-43.
40. Urrutia R. Exploring the role of homeobox and zinc finger proteins in pancreatic cell proliferation, differentiation, and apoptosis. Int J Pancreatol 1997; 22: 1-14.
41. Imanishi M, Hori Y, Nagaoka M, Sugiura Y. Design of novel zinc finger proteins: towards artificial control of specific gene expression. Eur J Pharm Sci 2001; 13: 91-97.
42. Collins L, Gustafsson K, Fabre JW. Tissue-binding properties of a synthetic peptide DNA vector targeted to cell membrane integrins: a possible universal nonviral vector for organ and tissue transplantation. Transplantation 2000; 69: 1041-1050.
43. Kircheis R, Wightman L, Wagner E. Design and gene delivery activity of modified polyethylenimines. Adv Drug Deliv Rev 2001; 53: 341-358.
44. Hofland HE, Nagy D, Liu JJ, et al. In vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex. Pharm Res 1997; 14: 742-749.
45. Takeshita S, Gal D, Leclerc G, et al. Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury. J Clin Invest 1994; 93: 652-661.
46. Yau TM, Fung K, Weisel RD, Fujii T, Mickle DA, Li RK. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation 2001; 104: I218-1222.
47. Richter M, Iwata A, Nyhuis J, et al. Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo. Physiol Genomics 2000; 2: 117-127.
48. Work LM, Nicklin SA, Brain NJ, et al. Development of efficient viral vectors selective for vascular smooth muscle cells. Mol Ther 2004; 9: 198-208.